|
1.
AIBN site, The University of Queensland Sep 20, 2007 ... Single Molecule Nanobiotechnology - Krassen Dimitrov ... Prior to joining AIBN Dr. Dimitrov was the Founder and Chief Scientific Officer of ... 2.
AIBN site, Single Molecule Nanobiotechnology - Krassen Dimitrov Sep 20, 2007 ... Krassen is in the process of building a diverse multidisciplinary group with expertise in nanoelectronics, electrochemistry, ... 3.
Tissue engineering the meniscus File Format: PDF/Adobe Acrobat - View as HTML a damaged meniscus or no meniscus at all. “Unlike other body tissues, the meniscus does not repair itself because only a very small part receives blood, ... 4.
Tissue engineering the meniscus File Format: PDF/Adobe Acrobat - View as HTML the artificial environment as well as the insertion method. “We also need to be able to grow, or manufacture, the artificial meniscus ... 5.
AIBN - Australian Institute for Bioengineering & Nanotechnology ... Aug 4, 2008 ... Information about AIBN - Australian Institute for Bioengineering & Nanotechnology at UQ. 6.
AIBN site, The University of Queensland A/Prof Darren Martin, Prof Rod Minchin and A/Prof Peter Halley (UQ); Dr Martin Svehla (Cochlear Ltd); Dr Ajay Padsalgikar (Aortech Biomaterials Pty) ... 7.
AIBN Confirmation Procedure SUMMARY Introduction File Format: PDF/Adobe Acrobat - View as HTML Confirmation. Procedure. Once the assessment is complete the Candidate and ... Confirmation. Procedure. Students should be notified of their impending ... 8.
AIBN - Australian Institute for Bioengineering & Nanotechnology ... Aug 4, 2008 ... Information about AIBN - Australian Institute for Bioengineering & Nanotechnology at UQ. 9.
AIBN - Australian Institute for Bioengineering & Nanotechnology ... Aug 4, 2008 ... Information about AIBN - Australian Institute for Bioengineering & Nanotechnology at UQ. 10.
Mammalian cell lines and stem cell biology bioprocesses File Format: PDF/Adobe Acrobat - View as HTML Mammalian cell lines and stem cell biology bioprocesses. GROUP LEADER: PROFESSOR PETER GRAY. NEW BIOPHARMACEUTICALS, THE CLASS OF PROTEIN-BASED HUMAN ... |
